Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,263 | 431 | 99.6% |
| Education | $53.70 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,403 | 89 | $0 (2024) |
| Amgen Inc. | $3,239 | 80 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,028 | 29 | $0 (2024) |
| Amarin Pharma Inc. | $1,003 | 61 | $0 (2023) |
| GlaxoSmithKline, LLC. | $992.81 | 40 | $0 (2024) |
| PFIZER INC. | $848.84 | 29 | $0 (2024) |
| Novo Nordisk Inc | $809.38 | 31 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $473.72 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $432.41 | 12 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $418.63 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,094 | 38 | AstraZeneca Pharmaceuticals LP ($225.18) |
| 2023 | $1,651 | 47 | Amgen Inc. ($699.92) |
| 2022 | $1,126 | 44 | AstraZeneca Pharmaceuticals LP ($402.49) |
| 2021 | $1,704 | 78 | AstraZeneca Pharmaceuticals LP ($500.47) |
| 2020 | $1,500 | 56 | Amgen Inc. ($474.88) |
| 2019 | $2,097 | 49 | AstraZeneca Pharmaceuticals LP ($592.30) |
| 2018 | $2,135 | 52 | AstraZeneca Pharmaceuticals LP ($624.26) |
| 2017 | $3,009 | 73 | Amgen Inc. ($757.69) |
All Payment Transactions
437 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $121.86 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Bone Health | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Respiratory | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: DIABETES | ||||||
| 07/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Cardiology | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 398 | 804 | $102,141 | $55,263 |
| 2022 | 11 | 456 | 747 | $101,656 | $65,816 |
| 2021 | 10 | 394 | 829 | $93,573 | $66,604 |
| 2020 | 11 | 427 | 819 | $84,886 | $60,368 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 230 | $31,408 | $20,833 | 66.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 106 | $20,523 | $12,996 | 63.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $5,407 | $5,201 | 96.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 120 | $15,360 | $4,993 | 32.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 120 | $15,360 | $4,810 | 31.3% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 62 | 71 | $8,670 | $3,300 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 30 | $2,946 | $1,942 | 65.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 52 | 56 | $1,218 | $604.50 | 49.6% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 18 | 18 | $684.00 | $292.14 | 42.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 13 | 14 | $563.92 | $291.98 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 276 | $42,319 | $25,145 | 59.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 73 | 114 | $20,898 | $13,492 | 64.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $8,826 | $8,632 | 97.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 66 | $7,215 | $5,365 | 74.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 19 | $5,260 | $3,917 | 74.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 64 | 68 | $7,861 | $3,195 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 37 | $3,554 | $2,428 | 68.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $2,359 | $1,696 | 71.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 15 | $1,335 | $986.91 | 73.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 58 | 66 | $1,507 | $742.65 | 49.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 11 | 11 | $520.74 | $216.01 | 41.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 314 | $36,539 | $24,913 | 68.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 73 | 123 | $19,055 | $13,573 | 71.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 30 | 152 | $17,059 | $13,125 | 76.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 22 | $4,925 | $3,687 | 74.9% |
About Dr. Arthur Ostrowski, M.D
Dr. Arthur Ostrowski, M.D is a Internal Medicine healthcare provider based in Barrington, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740257062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Ostrowski, M.D has received a total of $14,317 in payments from pharmaceutical and medical device companies, with $1,094 received in 2024. These payments were reported across 437 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($14,263).
As a Medicare-enrolled provider, Ostrowski has provided services to 1,675 Medicare beneficiaries, totaling 3,199 services with total Medicare billing of $248,052. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Barrington, IL
- Active Since 03/06/2006
- Last Updated 10/18/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740257062
Products in Payments
- FARXIGA (Drug) $1,807
- Repatha (Biological) $1,287
- ELIQUIS (Drug) $1,085
- Vascepa (Drug) $1,003
- Otezla (Drug) $824.20
- JARDIANCE (Drug) $752.97
- Prolia (Biological) $666.19
- TRELEGY ELLIPTA (Drug) $599.68
- BREZTRI (Drug) $518.37
- Ozempic (Drug) $489.83
- XIFAXAN (Drug) $472.19
- XARELTO (Drug) $418.63
- BYDUREON (Drug) $377.41
- SYMBICORT (Drug) $357.20
- Aimovig (Biological) $288.85
- STIOLTO RESPIMAT (Drug) $248.85
- ANORO (Drug) $180.11
- BEVESPI AEROSPHERE (Drug) $164.48
- EVENITY (Biological) $163.11
- VRAYLAR (Drug) $156.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Barrington
John Gong, Md, MD
Internal Medicine — Payments: $12,312
Dr. Elizabeth Elliott, D.o, D.O
Internal Medicine — Payments: $5,787
Tasbirul Islam, Md, MD
Internal Medicine — Payments: $2,934
Allen Dennison, M.d, M.D
Internal Medicine — Payments: $2,904
Dr. Arvind Maheshwari, Md, MD
Internal Medicine — Payments: $1,981
Behzad Farah, Md, MD
Internal Medicine — Payments: $1,594